Rocket Pharmaceuticals (RCKT) Times Interest Earned (2016 - 2025)
Historic Times Interest Earned for Rocket Pharmaceuticals (RCKT) over the last 9 years, with Q3 2025 value amounting to -$110.46.
- Rocket Pharmaceuticals' Times Interest Earned rose 2506.04% to -$110.46 in Q3 2025 from the same period last year, while for Sep 2025 it was -$132.46, marking a year-over-year increase of 890.16%. This contributed to the annual value of -$144.86 for FY2024, which is 460.32% down from last year.
- Latest data reveals that Rocket Pharmaceuticals reported Times Interest Earned of -$110.46 as of Q3 2025, which was up 2506.04% from -$150.42 recorded in Q2 2025.
- Rocket Pharmaceuticals' Times Interest Earned's 5-year high stood at -$22.68 during Q1 2021, with a 5-year trough of -$156.5 in Q2 2024.
- In the last 5 years, Rocket Pharmaceuticals' Times Interest Earned had a median value of -$134.64 in 2023 and averaged -$124.2.
- As far as peak fluctuations go, Rocket Pharmaceuticals' Times Interest Earned plummeted by 92835.36% in 2021, and later surged by 2506.04% in 2025.
- Over the past 5 years, Rocket Pharmaceuticals' Times Interest Earned (Quarter) stood at -$95.75 in 2021, then crashed by 54.49% to -$147.93 in 2022, then rose by 8.98% to -$134.64 in 2023, then increased by 1.55% to -$132.55 in 2024, then grew by 16.66% to -$110.46 in 2025.
- Its Times Interest Earned was -$110.46 in Q3 2025, compared to -$150.42 in Q2 2025 and -$136.42 in Q1 2025.